|
Indo US Bio-Tech Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
227.43 Cr.
|
P/BV
|
2.54
|
Book Value (Rs.)
|
44.72
|
|
52 Week High/Low (Rs.)
|
206/105
|
FV/ML
|
10/1
|
P/E(X)
|
13.98
|
|
Bookclosure
|
03/12/2024
|
EPS (Rs.)
|
8.11
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 24.55 | 25.51 |
| Total Income From Operations | 24.55 | 25.51 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | -22.40 | 24.58 |
| Purchase of Traded Goods | 44.17 | 1.02 |
| Increase/Decrease in Stocks | -4.85 | -6.36 |
| Employees Cost | 0.41 | 0.30 |
| Depreciation | 0.32 | 0.14 |
| Other Expenses | 3.76 | 2.66 |
| Total Expenses | 21.42 | 22.34 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.13 | 3.17 |
| Other Income | 0.16 | 0.02 |
| P/L Before Interest, Excpt. Items & Tax | 3.29 | 3.20 |
| Interest | 0.57 | 0.61 |
| P/L Before Exceptional Items & Tax | 2.72 | 2.59 |
| P/L Before Tax | 2.72 | 2.59 |
| Tax | 0.12 | 0.13 |
| P/L After Tax from Ordinary Activities | 2.60 | 2.46 |
| Net Profit/Loss For the Period | 2.60 | 2.46 |
| Net P/L After Minority Interest & Share Of Associates | 2.60 | 2.46 |
| | | |
| Equity Share Capital | 9.17 | 6.07 |
| Reserves And Surplus | 29.71 | 0.00 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.84 | 4.06 |
| Diluted EPS (Rs.) | 2.84 | 4.06 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 2.84 | 4.06 |
| Diluted EPS (Rs.) | 2.84 | 4.06 |
| | | |
| PBITOE Margin (%) | 12.75 | 12.44 |
| PBTE Margin (%) | 11.09 | 10.14 |
| PBT Margin (%) | 11.09 | 10.14 |
| PAT Margin (%) | 10.59 | 9.65 |
| PAT After MI And SOA Margin (%) | 10.59 | 9.65 |
